304 related articles for article (PubMed ID: 22322056)
41. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
Yasuda H; Toiyama Y; Ohi M; Mohri Y; Miki C; Kusunoki M
J Surg Oncol; 2011 Jun; 103(7):695-9. PubMed ID: 21308684
[TBL] [Abstract][Full Text] [Related]
42. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis.
Takano Y; Kato Y; Masuda M; Ohshima Y; Okayasu I
J Pathol; 1999 Oct; 189(2):194-200. PubMed ID: 10547574
[TBL] [Abstract][Full Text] [Related]
43. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
44. Is tumor size a prognostic indicator for gastric carcinoma?
Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
[TBL] [Abstract][Full Text] [Related]
45. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
[TBL] [Abstract][Full Text] [Related]
46. Expression of phosphorylated sphingosine kinase 1 is associated with diffuse type and lymphatic invasion in human gastric cancer.
Hanyu T; Nagahashi M; Ichikawa H; Ishikawa T; Kobayashi T; Wakai T
Surgery; 2018 Jun; 163(6):1301-1306. PubMed ID: 29370930
[TBL] [Abstract][Full Text] [Related]
47. [The expression and clinical significance of SphK1 and nuclear factor-κB p65 in human colon carcinoma].
Su YJ; Huang JA; Liu SQ; Huang JX; Zhong YY; Tang GD; Jiang HX
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):220-4. PubMed ID: 22781898
[TBL] [Abstract][Full Text] [Related]
48. Leptin and HER-2 are associated with gastric cancer progression and prognosis of patients.
Geng Y; Wang J; Wang R; Wang K; Xu Y; Song G; Wu C; Yin Y
Biomed Pharmacother; 2012 Sep; 66(6):419-24. PubMed ID: 22883999
[TBL] [Abstract][Full Text] [Related]
49. [Association of SOX9 expression and prognosis in patients with gastric cancer].
Shao CM; Shao QS; Yao HB; Zhao ZK; Xu J; Zhao ZS; Tao HQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jul; 15(7):736-9. PubMed ID: 22851082
[TBL] [Abstract][Full Text] [Related]
50. Absence of RKIP expression is an independent prognostic biomarker for gastric cancer patients.
Martinho O; Simões K; Longatto-Filho A; Jacob CE; Zilberstein B; Bresciani C; Gama-Rodrigues J; Cecconello I; Alves V; Reis RM
Oncol Rep; 2013 Feb; 29(2):690-6. PubMed ID: 23232914
[TBL] [Abstract][Full Text] [Related]
51. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM
J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702
[TBL] [Abstract][Full Text] [Related]
52. Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer.
Wang B; Li GX; Zhang SG; Wang Q; Wen YG; Tang HM; Zhou CZ; Xing AY; Fan JW; Yan DW; Qiu GQ; Yu ZH; Peng ZH
Exp Biol Med (Maywood); 2011 Nov; 236(11):1247-53. PubMed ID: 21998129
[TBL] [Abstract][Full Text] [Related]
53. High expression of heparanase-2 is an independent prognostic parameter for favorable survival in gastric cancer patients.
Zhang X; Xu S; Tan Q; Liu L
Cancer Epidemiol; 2013 Dec; 37(6):1010-3. PubMed ID: 24139593
[TBL] [Abstract][Full Text] [Related]
54. Ezrin is associated with gastric cancer progression and prognosis.
Li L; Wang YY; Zhao ZS; Ma J
Pathol Oncol Res; 2011 Dec; 17(4):909-15. PubMed ID: 21717114
[TBL] [Abstract][Full Text] [Related]
55. [Expressions of Jumonji domain containing protein 2C and hypoxia-inducible factor-1α in gastric carcinoma and their clinical significance].
Xu Y; Yao HB; Jin Y; Ma YY; Wang HJ; Shao QS
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3375-8. PubMed ID: 24418035
[TBL] [Abstract][Full Text] [Related]
56. CD24 expression is associated with progression of gastric cancer.
Takahashi M; Nakajima M; Ogata H; Domeki Y; Ohtsuka K; Ihara K; Kurayama E; Yamaguchi S; Sasaki K; Miyachi K; Kato H
Hepatogastroenterology; 2013 Jun; 60(124):653-8. PubMed ID: 23159387
[TBL] [Abstract][Full Text] [Related]
57. [Expression of multiple tumor suppressor gene p16 and its relationship with prognosis of gastric cancer patients].
Ma JM; Shi ZJ; Chen L; Hu HZ; Wang WG; Su CQ; Yang CP
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):21-5. PubMed ID: 22490850
[TBL] [Abstract][Full Text] [Related]
58. [Expression of metastasis associated 1 family member 2 (MTA2) in gastric cancer and its relationship with transcription factor Sp1].
Zhou CF; Ji J; Yuan F; Yu YY; Liu BY; Zhang J; Zhu ZG
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):592-5. PubMed ID: 23158992
[TBL] [Abstract][Full Text] [Related]
59. Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer.
Bae GE; DO SI; Kim K; Park JH; Cho S; Kim HS
Anticancer Res; 2019 Feb; 39(2):663-670. PubMed ID: 30711943
[TBL] [Abstract][Full Text] [Related]
60. Reduced Krüppel-like factor 17 (KLF17) expression correlates with poor survival in patients with gastric cancer.
Peng JJ; Wu B; Xiao XB; Shao YS; Feng Y; Yin MX
Arch Med Res; 2014 Jul; 45(5):394-9. PubMed ID: 24947617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
